Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cichoriin is a naturally occurring coumarin glycoside found in plants such as chicory (Cichorium intybus), Fraxinus insularis, and Chondrilla juncea. It consists of a coumarin core with a glucose moiety attached. As a member of the coumarins class and specifically a glycosylated derivative (glucoside), cichoriin has been studied for its photosensitizing properties and potential use as an herbal photosensitizing agent in experimental models of benign breast tumors in rats. In vitro studies suggest it does not exhibit significant neuroprotective or antioxidant activity compared to other flavonoids. There is also preliminary evidence that it may have activity against SARS-CoV‑2 in laboratory settings[1][2][5][9]. However, robust clinical data on its pharmacological effects or therapeutic uses are lacking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cichoriin.